Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Sunrest Lifescience IPO is a fixed price issue of Rs 10.85 crores. The issue is entirely a fresh issue of 12.91 lakh shares.
Sunrest Lifescience IPO bidding started from November 7, 2023 and ended on November 9, 2023. The allotment for Sunrest Lifescience IPO was finalized on Wednesday, November 15, 2023. The shares got listed on NSE SME on November 20, 2023.
Sunrest Lifescience IPO price is ₹84 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹134,400. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹268,800.
Mark Corporate Advisors Private Limited is the book running lead manager of the Sunrest Lifescience IPO, while Skyline Financial Services Private Ltd is the registrar for the issue. The market maker for Sunrest Lifescience IPO is Svcm Securities.
Refer to Sunrest Lifescience IPO RHP for detailed information.
| IPO Date | November 7, 2023 to November 9, 2023 |
| Listing Date | November 20, 2023 |
| Face Value | ₹10 per share |
| Price | ₹84 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 1,291,200 shares (aggregating up to ₹10.85 Cr) |
| Fresh Issue | 1,291,200 shares (aggregating up to ₹10.85 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 3,000,000 |
| Share holding post issue | 4,291,200 |
| Market Maker portion | 65,600 shares Svcm Securities |
Sunrest Lifescience IPO offers 1,291,200 shares. 612,800 (47.46%) to NII, 612,800 (47.46%) to RII.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | - |
| Market Maker Shares Offered | 65,600 (5.08%) |
| Other Shares Offered | 612,800 (47.46%) |
| Retail Shares Offered | 612,800 (47.46%) |
| Total Shares Offered | 1,291,200 (100%) |
Sunrest Lifescience IPO opens on November 7, 2023, and closes on November 9, 2023.
| IPO Open Date | Tuesday, November 7, 2023 |
| IPO Close Date | Thursday, November 9, 2023 |
| Basis of Allotment | Wednesday, November 15, 2023 |
| Initiation of Refunds | Thursday, November 16, 2023 |
| Credit of Shares to Demat | Friday, November 17, 2023 |
| Listing Date | Monday, November 20, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 9, 2023 |
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹134,400 |
| Retail (Max) | 1 | 1600 | ₹134,400 |
| HNI (Min) | 2 | 3,200 | ₹268,800 |
| Lot Size Calculator | |||
The promoters of the company are Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar.
| Share Holding Pre Issue | 100% |
| Share Holding Post Issue | 69.91% |
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 1,706.28 | 1,671.37 | 1,301.97 | 948.15 |
| Revenue | 563.58 | 2,467.05 | 2,690.99 | 1,694.91 |
| Profit After Tax | 75.08 | 204.31 | 77.71 | 16.55 |
| Net Worth | 386.60 | 311.52 | 107.20 | 29.49 |
| Reserves and Surplus | 86.60 | 11.52 | 106.20 | 28.49 |
| Total Borrowing | 347.32 | 214.32 | 323.83 | 231.55 |
| Amount in ₹ Lakhs | ||||
The market capitalization of Sunrest Lifescience IPO is Rs 36.05 Cr.
| KPI | Values |
|---|---|
| ROE | 53% |
| ROCE | 98% |
| Debt/Equity | 0.64 |
| RoNW | 65.59% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 6.81 | |
| P/E (x) | 12.33 | 12 |
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
1. Meeting Working Capital Requirements
2. General Corporate Purpose
3. Meeting Public Issue Expenses
[Dilip Davda] The company operates on third party contract model of pharma business. It marked inconsistency in its top lines for the reported periods and sudden surge in bottom lines for the last 15 months’ performance that raises concern over the sustainability. Based on annualized FY24 super earnings, the issue appears fully priced. The small equity post-IPO indicates longer duration for migration to mainboard. Well-informed/cash surplus investors may park funds for the long-term rewards. Read detail review...
The Sunrest Lifescience IPO is subscribed 48.54 times on November 9, 2023 7:29:00 PM. The public issue subscribed 65.74 times in the retail category, times in the QIB category, and 29.17 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 29.17 |
| Retail | 65.74 |
| Total | 48.54 |
Total Application : 25,179 (65.74 times)
| Listing Date | November 20, 2023 |
| BSE Script Code | |
| NSE Symbol | SUNREST |
| ISIN | INE0PLZ01012 |
| Final Issue Price | ₹84 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹84.00 |
| ₹84.00 |
| ₹79.80 |
| ₹84.00 |
| ₹79.80 |
Sunrest Lifescience Limited
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar, Bus Stand Vastral Road,
Ahmedabad-382415
Phone: +91-079 - 29918245
Email: info@sunrestlifescience.com
Website: https://sunrestlifescience.com/
Skyline Financial Services Private Ltd
Phone: 02228511022
Email: Virenr@Skylinerta.Com
Website: https://www.skylinerta.com/ipo.php
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Sunrest Lifescience IPO is a SME IPO of 1,291,200 equity shares of the face value of ₹10 aggregating up to ₹10.85 Crores. The issue is priced at ₹84 per share. The minimum order quantity is 1600 Shares.
The IPO opens on November 7, 2023, and closes on November 9, 2023.
Skyline Financial Services Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sunrest Lifescience IPO using UPI as a payment gateway. Zerodha customers can apply in Sunrest Lifescience IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sunrest Lifescience IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sunrest Lifescience IPO opens on November 7, 2023 and closes on November 9, 2023.
Sunrest Lifescience IPO lot size is 1600 Shares, and the minimum amount required is ₹134,400.
You can apply in Sunrest Lifescience IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Sunrest Lifescience IPO will be done on Wednesday, November 15, 2023, and the allotted shares will be credited to your demat account by Friday, November 17, 2023. Check the Sunrest Lifescience IPO allotment status.
Top Contributor (200+ Posts, 100+ Likes)
Top Contributor (200+ Posts, 100+ Likes)
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Mentor (600+ Posts, 200+ Likes)
IPO Guru (1200+ Posts, 800+ Likes)
